Role of ADAM and ADAMTS metalloproteinases in airway diseases

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Paulissen, Genevieve ^a   Rocks, Natacha ^a   Gueders, Maud M ^a   Crahay, Celine ^a   Quesada Calvo, Florence ^a   Bekaert, Sandrine ^a   Hacha, Jonathan ^a   El Hour, Mehdi ^a   Foidart, Jean Michel ^a   Noel, Agnes ^a   Cataldo, Didier D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS; ADAM 12 PROTEIN; ADAM 17 PROTEIN; ADAM 19 PROTEIN; ADAM 28 PROTEIN; ADAM 33 PROTEIN; ADAM 8 PROTEIN; ADAM 9 PROTEIN; ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAMTS 12 PROTEIN; ADAMTS 15 PROTEIN; ADAMTS1 PROTEIN; METALLOPROTEINASE; PROTEINASE; UNCLASSIFIED DRUG;

ASTHMA; AUSTRALIA; CAUCASIAN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; ENZYME ACTIVITY; ENZYME STRUCTURE; EPITHELIUM CELL; EUROPEAN AMERICAN; GENETIC POLYMORPHISM; GERMANY; HISPANIC; HUMAN; INFLAMMATORY CELL; JAPANESE; LUNG ALVEOLUS CELL; LUNG FUNCTION; PATHOGENESIS; PHENOTYPE; PHYSIOLOGY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SMOOTH MUSCLE FIBER; UNITED KINGDOM; ANIMAL; BIOLOGICAL MODEL; LUNG; LUNG DISEASE; METABOLISM;

ADAM PROTEINS; ANIMALS; HUMANS; LUNG; LUNG DISEASES; MODELS, BIOLOGICAL;

EID: 77449125516     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-127     Document Type: Review

References (100)

1. Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P, Michel FB. Asthma: a disease remodeling the airways. Allergy 1992, 47(1):3-11. 10.1111/j.1398-9995.1992.tb02242.x, 1590563.
2. Cataldo D, Louis R, Godon A, Munaut C, Noel A, Foidart JM, Bartsch P. [Bronchial morphologic modification in asthma]. Rev Med Liege 2000, 55(7):715-720.
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23(6):932-946. 10.1183/09031936.04.00014304, 15219010.
4. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164(10 Pt 2):S28-38.
5. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364(9434):613-620. 10.1016/S0140-6736(04)16855-4, 15313363.
6. Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol 2009,
7. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 2007, 87(1):69-98. 10.1152/physrev.00022.2006, 2656382, 17237343.
8. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006, 533(1-3):133-144. 10.1016/j.ejphar.2005.12.082, 16487964.
9. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001, 2(1):10-19. 10.1186/rr33, 59564, 11686860.
10. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005, 386(Pt 1):15-27. 1134762, 15554875.
11. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003, 17(1):7-30. 10.1101/gad.1039703, 12514095.
12. Killar L, White J, Black R, Peschon J. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). Ann N Y Acad Sci 1999, 878:442-452. 10.1111/j.1749-6632.1999.tb07701.x, 10415747.
13. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol 1998, 10(5):654-659. 10.1016/S0955-0674(98)80042-2, 9818177.
14. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008, 90(2):369-379. 10.1016/j.biochi.2007.08.008, 17920749.
15. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008, 8(12):929-941. 10.1038/nrc2459, 19005493.
16. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385(6618):729-733. 10.1038/385729a0, 9034190.
17. Rocks N, Estrella C, Paulissen G, Quesada-Calvo F, Gilles C, Gueders MM, Crahay C, Foidart JM, Gosset P, Noel A, Cataldo DD. The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif 2008, 41(6):988-1001. 10.1111/j.1365-2184.2008.00557.x, 19040574.
18. Weskamp G, Ford JW, Sturgill J, Martin S, Docherty AJ, Swendeman S, Broadway N, Hartmann D, Saftig P, Umland S, Sehara-Fujisawa A, Black RA, Ludwig A, Becherer JD, Conrad DH, Blobel CP. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 2006, 7(12):1293-1298. 10.1038/ni1399, 17072319.
19. Lemieux GA, Blumenkron F, Yeung N, Zhou P, Williams J, Grammer AC, Petrovich R, Lipsky PE, Moss ML, Werb Z. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem 2007, 282(20):14836-14844. 10.1074/jbc.M608414200, 2582392, 17389606.
20. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, Oxvig C. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 2001, 358(Pt 2):359-367. 10.1042/0264-6021:3580359, 1222068, 11513734.
21. Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 2006, 20(5):983-1002. 10.1016/j.berh.2006.06.007, 16980219.
22. Gomis-Ruth FX. Catalytic domain architecture of metzincin metalloproteases. J Biol Chem 2009, 284(23):15353-15357. 10.1074/jbc.R800069200, 19201757.
23. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995, 4(5):823-840. 2143131, 7663339.
24. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 2003, 270(11):2386-2393. 10.1046/j.1432-1033.2003.03606.x, 12755693.
25. Howard L, Maciewicz RA, Blobel CP. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J 2000, 348(Pt 1):21-27. 10.1042/0264-6021:3480021, 1221031, 10794709.
26. Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJ, Lambert M, Skelton L, Jockusch H, Bartsch JW. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem 2002, 277(50):48210-48219. 10.1074/jbc.M203355200, 12372841.
27. Jones GC, Riley GP. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther 2005, 7(4):160-169. 10.1186/ar1783, 1175049, 15987500.
28. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998, 435(1):39-44. 10.1016/S0014-5793(98)01031-X, 9755855.
29. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, Docherty AJ, Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000, 473(3):275-279. 10.1016/S0014-5793(00)01528-3, 10818225.
30. Wayne GJ, Deng SJ, Amour A, Borman S, Matico R, Carter HL, Murphy G. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. J Biol Chem 2007, 282(29):20991-20998. 10.1074/jbc.M610721200, 17470431.
31. Wang WM, Ge G, Lim NH, Nagase H, Greenspan DS. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem J 2006, 398(3):515-519. 10.1042/BJ20060630, 1559475, 16771712.
32. Wisniewska M, Goettig P, Maskos K, Belouski E, Winters D, Hecht R, Black R, Bode W. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. J Mol Biol 2008, 381(5):1307-1319. 10.1016/j.jmb.2008.06.088, 18638486.
33. Troeberg L, Fushimi K, Scilabra SD, Nakamura H, Dive V, Thogersen IB, Enghild JJ, Nagase H. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. Matrix Biol 2009, 28(8):463-9. 10.1016/j.matbio.2009.07.005, 19643179.
34. Ortiz RM, Karkkainen I, Huovila AP. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells. Genes Chromosomes Cancer 2004, 41(4):366-378. 10.1002/gcc.20102, 15384173.
35. Primakoff P, Hyatt H, Tredick-Kline J. Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion. J Cell Biol 1987, 104(1):141-149. 10.1083/jcb.104.1.141, 2117034, 3793758.
36. Evans JP. Fertilin beta and other ADAMs as integrin ligands: insights into cell adhesion and fertilization. Bioessays 2001, 23(7):628-639. 10.1002/bies.1088, 11462216.
37. Lieber T, Kidd S, Young MW. kuzbanian-mediated cleavage of Drosophila Notch. Genes Dev 2002, 16(2):209-221. 10.1101/gad.942302, 155326, 11799064.
38. Ham C, Levkau B, Raines EW, Herren B. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin. Exp Cell Res 2002, 279(2):239-247. 10.1006/excr.2002.5606, 12243749.
39. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997, 385(6618):733-736. 10.1038/385733a0, 9034191.
40. Arner EC. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2002, 2(3):322-329. 10.1016/S1471-4892(02)00148-0, 12020478.
41. Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003, 5(2):94-103. 10.1186/ar630, 165039, 12718749.
42. Colige A, Ruggiero F, Vandenberghe I, Dubail J, Kesteloot F, Van Beeumen J, Beschin A, Brys L, Lapiere CM, Nusgens B. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J Biol Chem 2005, 280(41):34397-34408. 10.1074/jbc.M506458200, 16046392.
43. McGowan PM, McKiernan E, Bolster F, Ryan BM, Hill AD, McDermott EW, Evoy D, O'Higgins N, Crown J, Duffy MJ. ADAM-17 predicts adverse outcome in patients with breast cancer. Ann Oncol 2008, 19(6):1075-1081. 10.1093/annonc/mdm609, 18238782.
44. Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 2002, 277(25):22201-22208. 10.1074/jbc.M200431200, 11956193.
45. Majumdar MK, Askew R, Schelling S, Stedman N, Blanchet T, Hopkins B, Morris EA, Glasson SS. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007, 56(11):3670-3674. 10.1002/art.23027, 17968948.
46. Prinzen C, Trumbach D, Wurst W, Endres K, Postina R, Fahrenholz F. Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice. BMC Genomics 2009, 10:66. 10.1186/1471-2164-10-66, 2647556, 19196476.
47. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004, 113(10):1456-1464. 406531, 15146243.
48. Zolkiewska A. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Exp Cell Res 1999, 252(2):423-431. 10.1006/excr.1999.4632, 10527632.
49. Dijkstra A, Postma DS, Noordhoek JA, Lodewijk ME, Kauffman HF, ten Hacken NH, Timens W. Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung. Virchows Arch 2009, 454(4):441-449. 10.1007/s00428-009-0748-4, 19255780.
50. Rocks N, Paulissen G, Quesada Calvo F, Polette M, Gueders M, Munaut C, Foidart JM, Noel A, Birembaut P, Cataldo D. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer 2006, 94(5):724-730. 2361209, 16495931.
51. Paulissen G, Rocks N, Quesada-Calvo F, Gosset P, Foidart JM, Noel A, Louis R, Cataldo DD. Expression of ADAMs and their inhibitors in sputum from patients with asthma. Mol Med 2006, 12(7-8):171-179. 10.2119/2006-00028.Paulissen, 1626598, 17088949.
52. Keating DT, Sadlier DM, Patricelli A, Smith SM, Walls D, Egan JJ, Doran PP. Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells. Respir Res 2006, 7:114. 10.1186/1465-9921-7-114, 1569837, 16948840.
53. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418(6896):426-430. 10.1038/nature00878, 12110844.
54. Powell RM, Wicks J, Holloway JW, Holgate ST, Davies DE. The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am J Respir Cell Mol Biol 2004, 31(1):13-21. 10.1165/rcmb.2003-0330OC, 14742294.
55. Haitchi HM, Powell RM, Shaw TJ, Howarth PH, Wilson SJ, Wilson DI, Holgate ST, Davies DE. ADAM33 expression in asthmatic airways and human embryonic lungs. Am J Respir Crit Care Med 2005, 171(9):958-965. 10.1164/rccm.200409-1251OC, 15709049.
56. Yang Y, Haitchi HM, Cakebread J, Sammut D, Harvey A, Powell RM, Holloway JW, Howarth P, Holgate ST, Davies DE. Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells. J Allergy Clin Immunol 2008, 121(6):1393-1399. 1399 e1391-1314, 10.1016/j.jaci.2008.02.031, 18423563.
57. Foley SC, Mogas AK, Olivenstein R, Fiset PO, Chakir J, Bourbeau J, Ernst P, Lemiere C, Martin JG, Hamid Q. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol 2007, 119(4):863-871. 10.1016/j.jaci.2006.12.665, 17339047.
58. Chiba Y, Onoda S, Hattori Y, Maitani Y, Sakai H, Misawa M. Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma. Lung 2009, 187(3):179-185. 10.1007/s00408-009-9145-7, 19373511.
59. King NE, Zimmermann N, Pope SM, Fulkerson PC, Nikolaidis NM, Mishra A, Witte DP, Rothenberg ME. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am J Respir Cell Mol Biol 2004, 31(3):257-265. 10.1165/rcmb.2004-0026OC, 15087305.
60. Matsuno O, Miyazaki E, Nureki S, Ueno T, Kumamoto T, Higuchi Y. Role of ADAM8 in experimental asthma. Immunol Lett 2006, 102(1):67-73. 10.1016/j.imlet.2005.07.006, 16154205.
61. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161(5):1720-1745.
62. Bergeron C, Al-Ramli W, Hamid Q. Remodeling in asthma. Proc Am Thorac Soc 2009, 6(3):301-305. 10.1513/pats.200808-089RM, 19387034.
63. Noguchi E, Ohtsuki Y, Tokunaga K, Yamaoka-Sageshima M, Ichikawa K, Aoki T, Shibasaki M, Arinami T. ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin Exp Allergy 2006, 36(5):602-608. 10.1111/j.1365-2222.2006.02471.x, 16650044.
64. Werner M, Herbon N, Gohlke H, Altmuller J, Knapp M, Heinrich J, Wjst M. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004, 34(1):26-31. 10.1111/j.1365-2222.2004.01846.x, 14720258.
65. Howard TD, Postma DS, Jongepier H, Moore WC, Koppelman GH, Zheng SL, Xu J, Bleecker ER, Meyers DA. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol 2003, 112(4):717-722. 10.1016/S0091-6749(03)01939-0, 14564349.
66. Hirota T, Hasegawa K, Obara K, Matsuda A, Akahoshi M, Nakashima K, Shirakawa T, Doi S, Fujita K, Suzuki Y, Nakamura Y, Tamari M. Association between ADAM33 polymorphisms and adult asthma in the Japanese population. Clin Exp Allergy 2006, 36(7):884-891. 10.1111/j.1365-2222.2006.02522.x, 16839403.
67. Wang P, Liu QJ, Li JS, Li HC, Wei CH, Guo CH, Gong YQ. Lack of association between ADAM33 gene and asthma in a Chinese population. Int J Immunogenet 2006, 33(4):303-306. 10.1111/j.1744-313X.2006.00617.x, 16893396.
68. Lind DL, Choudhry S, Ung N, Ziv E, Avila PC, Salari K, Ha C, Lovins EG, Coyle NE, Nazario S, Casal J, Torres A, Rodriguez-Santana JR, Matallana H, Lilly CM, Salas J, Selman M, Boushey HA, Weiss ST, Chapela R, Ford JG, Rodriguez-Cintron W, Silverman EK, Sheppard D, Kwok PY, González Burchard E. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003, 168(11):1312-1316. 10.1164/rccm.200306-877OC, 12958057.
69. Garlisi CG, Zou J, Devito KE, Tian F, Zhu FX, Liu J, Shah H, Wan Y, Motasim Billah M, Egan RW, Umland SP. Human ADAM33: protein maturation and localization. Biochem Biophys Res Commun 2003, 301(1):35-43. 10.1016/S0006-291X(02)02976-5, 12535637.
70. Puxeddu I, Pang YY, Harvey A, Haitchi HM, Nicholas B, Yoshisue H, Ribatti D, Clough G, Powell RM, Murphy G, Hanley NA, Wilson DI, Howarth PH, Holgate ST, Davies DE. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J Allergy Clin Immunol 2008, 121(6):1400-1406. 1406 e1401-1404, 10.1016/j.jaci.2008.03.003, 18410963.
71. Jie Z, Jin M, Cai Y, Bai C, Shen Y, Yuan Z, Hu Y, Holgate S. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir Physiol Neurobiol 2009, 168(3):289-294. 10.1016/j.resp.2009.07.019, 19635592.
72. Chen C, Huang X, Sheppard D. ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol Cell Biol 2006, 26(18):6950-6956. 10.1128/MCB.00646-06, 1592855, 16943435.
73. Di Valentin E, Crahay C, Garbacki N, Hennuy B, Gueders M, Noel A, Foidart JM, Grooten J, Colige A, Piette J, Cataldo D. New asthma biomarkers: lessons from murine models of acute and chronic asthma. Am J Physiol Lung Cell Mol Physiol 2009, 296(2):L185-197. 10.1152/ajplung.90367.2008, 19028979.
74. Tremblay K, Lemire M, Potvin C, Tremblay A, Hunninghake GM, Raby BA, Hudson TJ, Perez-Iratxeta C, Andrade-Navarro MA, Laprise C. Genes to diseases (G2D) computational method to identify asthma candidate genes. PLoS ONE 2008, 3(8):e2907. 10.1371/journal.pone.0002907, 2488373, 18682798.
75. Fourie AM, Coles F, Moreno V, Karlsson L. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem 2003, 278(33):30469-30477. 10.1074/jbc.M213157200, 12777399.
76. Naus S, Reipschlager S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol Chem 2006, 387(3):337-346. 10.1515/BC.2006.045, 16542157.
77. Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP. Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev Dyn 2005, 232(1):221-231. 10.1002/dvdy.20221, 15580619.
78. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005, 172(3):329-333. 10.1164/rccm.200411-1486OC, 15879414.
79. Gosman MM, Boezen HM, van Diemen CC, Snoeck-Stroband JB, Lapperre TS, Hiemstra PS, Ten Hacken NH, Stolk J, Postma DS. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007, 62(3):242-247. 10.1136/thx.2006.060988, 17090574.
80. Ju CR, Xia XZ, Chen RC. Expressions of tumor necrosis factor-converting enzyme and ErbB3 in rats with chronic obstructive pulmonary disease. Chin Med J (Engl) 2007, 120(17):1505-1510.
81. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 2004, 287(2):L420-427. 10.1152/ajplung.00019.2004, 15121636.
82. Ito I, Laporte JD, Fiset PO, Asai K, Yamauchi Y, Martin JG, Hamid Q. Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells. J Allergy Clin Immunol 2007, 119(1):89-97. 10.1016/j.jaci.2006.08.038, 17208589.
83. Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA, Bleecker ER. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res 2009, 10:21. 10.1186/1465-9921-10-21, 2664793, 19284602.
84. Kurz T, Hoffjan S, Hayes MG, Schneider D, Nicolae R, Heinzmann A, Jerkic SP, Parry R, Cox NJ, Deichmann KA, Ober C. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol 2006, 118(2):396-402. 10.1016/j.jaci.2006.04.036, 16890764.
85. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 2004, 64(12):4190-4196. 10.1158/0008-5472.CAN-03-3235, 15205330.
86. Booth BW, Sandifer T, Martin EL, Martin LD. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res 2007, 8:51. 10.1186/1465-9921-8-51, 1976612, 17620132.
87. Haidl ID, Huber G, Eichmann K. An ADAM family member with expression in thymic epithelial cells and related tissues. Gene 2002, 283(1-2):163-170. 10.1016/S0378-1119(01)00871-X, 11867223.
88. Umland SP, Garlisi CG, Shah H, Wan Y, Zou J, Devito KE, Huang WM, Gustafson EL, Ralston R. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am J Respir Cell Mol Biol 2003, 29(5):571-582. 10.1165/rcmb.2003-0028OC, 12777249.
89. Lee JH, Park HS, Park SW, Jang AS, Uh ST, Rhim T, Park CS, Hong SJ, Holgate ST, Holloway JW, Shin HD. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy 2004, 34(6):860-865. 10.1111/j.1365-2222.2004.01977.x, 15196271.
90. Raby BA, Silverman EK, Kwiatkowski DJ, Lange C, Lazarus R, Weiss ST. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol 2004, 113(6):1071-1078. 10.1016/j.jaci.2004.03.035, 15208587.
91. Jongepier H, Boezen HM, Dijkstra A, Howard TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER, Postma DS. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004, 34(5):757-760. 10.1111/j.1365-2222.2004.1938.x, 15144468.
92. Simpson A, Maniatis N, Jury F, Cakebread JA, Lowe LA, Holgate ST, Woodcock A, Ollier WE, Collins A, Custovic A, Holloway JW, John SL. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med 2005, 172(1):55-60. 10.1164/rccm.200412-1708OC, 15805180.
93. Schedel M, Depner M, Schoen C, Weiland SK, Vogelberg C, Niggemann B, Lau S, Illig T, Klopp N, Wahn U, von Mutius E, Nickel R, Kabesch M. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir Res 2006, 7:91. 10.1186/1465-9921-7-91, 1550399, 16784537.
94. Kedda MA, Duffy DL, Bradley B, O'Hehir RE, Thompson PJ. ADAM33 haplotypes are associated with asthma in a large Australian population. Eur J Hum Genet 2006, 14(9):1027-1036. 10.1038/sj.ejhg.5201662, 16773130.
95. Hersh CP, Raby BA, Soto-Quiros ME, Murphy AJ, Avila L, Lasky-Su J, Sylvia JS, Klanderman BJ, Lange C, Weiss ST, Celedón JC. Comprehensive testing of positionally cloned asthma genes in two populations. Am J Respir Crit Care Med 2007, 176(9):849-857. 10.1164/rccm.200704-592OC, 2048676, 17702965.
96. Sakagami T, Jinnai N, Nakajima T, Sekigawa T, Hasegawa T, Suzuki E, Inoue I, Gejyo F. ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population. J Hum Genet 2007, 52(1):66-72. 10.1007/s10038-006-0081-6, 17061022.
97. Su D, Zhang X, Sui H, Lu F, Jin L, Zhang J. Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population. BMC Med Genet 2008, 9:-82. 10.1186/1471-2350-9-82, 2553063, 18778489.
98. Thongngarm T, Jameekornrak A, Limwongse C, Sangasapaviliya A, Jirapongsananuruk O, Assawamakin A, Chaiyaratana N, Luangwedchakarn V, Thongnoppakhun W. Association between ADAM33 polymorphisms and asthma in a Thai population. Asian Pac J Allergy Immunol 2008, 26(4):205-211.
99. Zhang X, Su D, Sui H, Jin L, Lu F, Zhang J. Association of ADAM33 gene polymorphisms with adult concomitant allergic rhinitis and asthma in Chinese Han population. Mol Biol Rep 2009, 36(6):1505-1509. 10.1007/s11033-008-9343-z, 18752037.
100. Blakey JD, Sayers I, Ring SM, Strachan DP, Hall IP. Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort. Thorax 2009, 64(5):381-387. 10.1136/thx.2008.102053, 19237393.